News

Patients diagnosed with the same type and grade of diffuse glioma can experience remarkably different disease courses. Understanding the biology behind these differences is essential for improving prognosis and advancing more personalised treatment strategies.

Since January, the Genomics Core Facility at Erasmus MC has welcomed a new bioinformatician: Minouk Noordsij. With an interdisciplinary academic background, she is driven by the challenge of transforming complex genomic data into insights with real-world relevance.

At the Erasmus MC Genomics Core Facility, we are proud to contribute to the ambitious Genome of Europe initiative — a pan-European effort to build a comprehensive reference genome cohort representing the genetic diversity of European citizens. This project will lay the foundation for advancing personalised medicine and improving healthcare across Europe.

Good news for researchers in proteomics! Because we value scientific progress and aim to contribute to large-scale proteomics research, we collaborated with Olink to form a Reveal research consortium. Through this strategic collaboration, we successfully negotiated a reduced rate for the Olink Reveal panel.

Illumina’s new generation of Infinium EX genotyping arrays includes the Global Screening Array v4 and the Global Clinical Research Array.

After months of hard work, we are excited to announce that our new website is officially live.